Weizmann Institute | GenomeWeb

Weizmann Institute

NRGene's software will be used to assemble the 12GB wild emmer wheat genome

NEW YORK (GenomeWeb) – In Nature Genetics, an international team led by investigators at Columbia and Yale Universities unveiled previously unknown risk loci for IgA nephropathy, a kidney condi

NEW YORK (GenomeWeb) – Rosetta Genomics announced today that it has begun collaborating with Israel's Weizmann Institute of Science on the development of new methods for the preparation of next-generation sequencing libraries for small RNAs.

NEW YORK (GenomeWeb News) – The Weizmann Institute of Science has received a $50 million donation to fund operations at the new Israel National Center for Personalized Medicine (INCPM), which is located at the Weizmann campus in Rehovot, Israel.

Name:
Eytan Domany
Position:
Professor, physics of complex systems, Weizmann Institute of Science

A team of researchers from the Weizmann Institute of Science said its approach, which found that protein-drug dynamics in multi-drug combinations can be predicted based on the dynamics in pairs of drugs, could be a way "to bypass the combinatorial explosion problem of research on drug combinations."

Prolor has the option to obtain from Yeda a license to develop a number of peptide drug candidates, including an anti-obesity peptide, using a delivery technology developed at the Weizmann Institute.

A group of researchers from Israel and the US report that they have characterized chromosomal abnormalities in different colorectal cancer stages and identified alterations associated with poor outcomes.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.